Helena Van Damme

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Lost and found: expectoration of a retained gallstone years after cholecystectomy.

Lost and found: expectoration of a retained gallstone years after cholecystectomy.

Journal: Thorax

Published: August 21, 2025

A 66-Year-Old Man with Intrapleural Leakage of Parenteral Nutrition Fluid Due to a Malpositioned Central Venous Catheter.

A 66-Year-Old Man with Intrapleural Leakage of Parenteral Nutrition Fluid Due to a Malpositioned Central Venous Catheter.

Journal: The American journal of case reports

Published: August 14, 2025

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Journal: Cancer research

Published: August 27, 2024

Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.

Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.

Journal: Frontiers in immunology

Published: July 26, 2022

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

Journal: Cancer research

Published: January 13, 2022

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth.

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth.

Journal: Frontiers in immunology

Published: September 08, 2021

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.

Journal: Journal for immunotherapy of cancer

Published: December 29, 2020

IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.

IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.

Journal: Cancer immunology research

Published: May 22, 2020

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.

Journal: Frontiers in immunology

Published: July 20, 2018

The role of hepatic macrophages in liver metastasis.

The role of hepatic macrophages in liver metastasis.

Journal: Cellular immunology

Published: October 21, 2017

Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.

Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.

Journal: The FEBS journal

Published: June 21, 2017

Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies.

Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies.

Journal: Journal of leukocyte biology

Published: November 06, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026